Sign In
Buy OSUR
$3.95
-0.0500 (-1.25%)
At Close: Jun 03, 2026
Strs Ohio Buys Shares of 62,900 OraSure Technologies, Inc. (NASDAQ:OSUR)
07:04am, Wednesday, 05'th Aug 2020
Strs Ohio bought a new stake in OraSure Technologies, Inc. (NASDAQ:OSUR) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm bought 62,900 shares of the medical
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
12:00am, Wednesday, 05'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...
Did Hedge Funds Make The Right Call On OraSure Technologies, Inc. (OSUR) ?
02:59pm, Tuesday, 04'th Aug 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
ABIOMED, Inc. (NASDAQ: ABMD)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Annexon Inc (NASDAQ: ANNX)
Atossa...
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
BETHLEHEM, Pa., July 31, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and anal
Clinical Reference Laboratory Receives FDA Emergency Use Authorization for Best-in-Class Self-Collected COVID-19 Saliva Test
03:23pm, Friday, 31'st Jul 2020
Today, Clinical Reference Laboratory (CRL), one of the largest privately held clinical testing laboratories in the U.S., announced that it received FDA Emergency Use Authorization (EUA) and is scaling
The Daily Biotech Pulse: Sanofi-GSK Land $2.1B Funding For Coronavirus Vaccine, D-Day For GW Pharma, FDA Nod For Roche
12:00am, Friday, 31'st Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 30)
Achieve Life Sciences Inc (NASDAQ: ACHV)
Annexon Inc (NASDAQ: ANNX) (IPOed July 24)
Atossa Therapeutics...
Earnings Preview: OraSure Technologies (OSUR) Q2 Earnings Expected to Decline
04:33pm, Wednesday, 29'th Jul 2020
OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OraSure Technologies to Hold Second Quarter 2020 Earnings Conference Call on August 5th, 2020
10:00am, Wednesday, 22'nd Jul 2020
2020 Second Quarter Earnings Conference Call Wednesday, August 5, 2020, 5:00 p.m. ETBETHLEHEM, Pa., July 22, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regu
The Global Microbiome Sequencing Services Market will grow by USD 914.65 mn during 2020-2024
OraSure Technologies, Inc. (NASDAQ:OSUR) Given Consensus Rating of “Hold” by Brokerages
06:56am, Monday, 20'th Jul 2020
Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) have received a consensus rating of “Hold” from the six brokerages that are covering the firm, Marketbeat Ratings reports. One analyst has rated
OraSure Technologies, Inc. (NASDAQ:OSUR) Expected to Announce Earnings of -$0.09 Per Share
12:04pm, Monday, 29'th Jun 2020
Wall Street brokerages expect OraSure Technologies, Inc. (NASDAQ:OSUR) to post ($0.09) earnings per share for the current quarter, according to Zacks. Two analysts have issued estimates for OraSure Te
Analysts Set OraSure Technologies, Inc. (NASDAQ:OSUR) PT at $14.75
07:31am, Sunday, 28'th Jun 2020
OraSure Technologies, Inc. (NASDAQ:OSUR) has received a consensus recommendation of “Buy” from the six analysts that are presently covering the firm, Marketbeat.com reports. Four investment analys
Diversigen, Inc. and Alimentiv Inc. Announce Collaboration Agreement for Ulcerative Colitis Research Study
12:00pm, Thursday, 25'th Jun 2020
Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (OSUR), and Alimentiv Inc. (formerly Robarts Clinical Trials) today announced they have signed a collaboration agreement for a research stud
